Revenue

With a top-tier sponsorship, DiamondLake signals its arrival in institutional blockchain. But do its financials and unfinalized deals support the hype?

eClerx brings back early leader Hoshi Mistry to steer its Customer Experience unit, signaling a strategic push to fuse institutional knowledge with AI innovation.

As HSDT prepares to report Q2 results, investors are watching closely. Is its unique strategy of tying shareholder value directly to the Solana ecosystem paying off?

Haoxi Health announces a second reverse split in three months, a move to save its Nasdaq listing that investors see as a red flag, despite its strategic AI push.

With Coco Gauff and Taylor Fritz, ŌURA isn't just selling a smart ring. It's selling a new philosophy of athletic success built on data, recovery, and story.

Cineverse is betting it can solve CTV's ad waste problem by turning podcast ads into TV spots. A deep dive into the tech, the strategy, and the $12M question.

A new composition of matter patent extends protection for Alterity's lead drug to 2045, de-risking its path in MSA and opening a new front against Parkinson's.

A new partnership aims to bring the first FDA-approved, oral ketamine pill for depression to your home, using AI and real-world data to ensure safety.

A new AI agent from Assort Health is automating the chaotic patient referral process, promising to recover lost revenue and get patients to care faster.

As Firehouse Subs opens its 1,500th store, we analyze its unique model blending franchisee success, a $115M mission, and RBI's strategic backing.

With revenue up 23%, Rubicon Organics invests heavily in new facility tech, temporarily squeezing profits to fuel its bid for long-term global dominance.

Magna5's fourth consecutive Inc. 5000 ranking is celebrated, but the real story is a blueprint for survival and growth in a volatile digital economy.

Early data for Sutro Biopharma's STRO-004 offers a glimmer of hope for advanced cancer patients. We look at the tech, the trials, and the financial tightrope.

With breakthrough dialysis data and a new heart-mending vessel, Humacyte is balancing radical innovation with commercial reality. Is this the future of medicine?

Riskified reports its strongest growth in four years, raising its outlook. Our analysis digs past the headlines to the execution behind its AI platform.

Beyond a simple payout, Ituran's latest dividend reveals a robust financial engine, savvy tax strategy, and a deep-seated plan to dominate the future of mobility.

Local Bounti posts 14% revenue growth and narrows losses, but a deep dive into its Q2 financials reveals the high-stakes reality of its path to profitability.

With sales declining, Shoe Station Group taps veteran marketer Tracy Dick. It's a strategic gamble on her ability to overhaul its brands and master omnichannel retail.

A tiny team made a hit show for $4k that drove 25% of a platform's revenue. This isn't a fantasy; it's the new reality of AI-driven entertainment.

Marti Technologies is rapidly expanding its ride-hailing empire across Türkiye. But behind impressive growth numbers lies a complex web of operational risks.